Our aim is to support the National Strategy for the Quality Use of Medicines.

The goal of the strategy is to make the best possible use of medicines to improve health outcomes for all Australians. We support this goal by providing free access to high quality, up to date information about medicines that are approved for use in Australia.

Pharmaceutical companies are required by government to keep the Product Information (PI) up to date as new information about medicines becomes available. This web site contains the most up to date version of Consumer Medicine Information (CMI) and PI that are available in Australia, as the web site is updated within hours of the release of the updated CMI and PI from the company

Updated products

Product name Type Date released
FluQuadri and FluQuadri Junior PI 15 Dec 2017
Etoposide Ebewe CMI 15 Dec 2017
Meloxicam Sandoz Capsules CMI 15 Dec 2017
Adenosine Mylan CMI 15 Dec 2017
Methylprednisolone Alphapharm CMI 15 Dec 2017

New products

Product name Type Date released
Sandoz Lamotrigine PI 08 Dec 2017
Esomeprazole SZ CMI 08 Dec 2017
Esomeprazole SZ PI 05 Dec 2017
APO-Ibuprofen 400 CMI 04 Dec 2017
APO-Ibuprofen 400 PI 04 Dec 2017